Clifford Stocks
Clifford Stocks is the founder of OncoResponse and currently leads the company. He previously served as Executive Officer and Director at OncoResponse Inc.
OncoResponse raises $150M total, closes $6M Series D in April 2025; backed by ARE, Rice University, Takeda
OncoResponse, headquartered in Seattle, has raised $150M total with a recorded $6M Series D round in April 2025 and is backed by investors including ARE, Rice University, and Takeda Pharmaceuticals.
OncoResponse Raises $27M to Advance Antibody-Based Cancer Immunotherapies OR502 and OR2805
Seattle biotech firm OncoResponse secured $27 million to advance testing of its antibody-based cancer immunotherapy candidates OR502 and OR2805. The funding includes a $13 million grant from the Cancer Prevention and Research Institute of Texas and $14 million from investors led by RiverVest Venture Partners.
OncoResponse raises $40M Series B to advance five antibody-based cancer immunotherapies into preclinical and clinical trials
OncoResponse raised $40 million in a Series B to push five antibody-based cancer immunotherapy candidates into preclinical and clinical studies, bringing total funding to nearly $70 million since its 2015 launch. The company mines antibodies from cancer patients who had exceptional responses to immunotherapy to develop treatments that modulate tumor‑microenvironment immunosuppression.
See all 4 stories, episodes and videos about Clifford Stocks.
Seattle Flow is free for everyone.
- Claim and edit your profile
- Get alerts about you, your company, and anything else you care about
- Access the most comprehensive investor list in Seattle
- Join the conversation on news, podcasts, and events
Organizations
See all 6-
OncoResponse Executive Officer, Director 2017–present, Chief Executive Officer 2015–present · current
-
Theraclone Sciences Chief Executive Officer 2011–2016 · past
-
Calistoga Pharmaceuticals (acquired by Gilead 2011) Chief Business Officer 2009–2011 · past
Education
-
The University of Chicago Booth School of Business MBA, Statistics; Operations; Leadership · 1986–1989
-
University of Utah B.S., Biology · 1976–1980